Pancreatic neuroendocrine neoplasms: diagnosis and management

Abdom Imaging. 2013 Apr;38(2):342-57. doi: 10.1007/s00261-012-9923-1.

Abstract

Pancreatic neuroendocrine neoplasms are uncommon but rising in incidence. There have been recent changes in the WHO nomenclature and a newly proposed American Joint Committee on Cancer TNM staging, which complement each other. These neoplasms are of great medical and radiological interest because of their diverse presenting features and imaging appearances. There is an increased role for both anatomic and functional imaging in the assessment of these neoplasms. A review of the nomenclature, staging, and imaging is presented in this paper.

MeSH terms

  • Carcinoma, Neuroendocrine / diagnosis*
  • Carcinoma, Neuroendocrine / secondary
  • Carcinoma, Neuroendocrine / surgery*
  • Endosonography
  • Gastrinoma / diagnosis
  • Gastrointestinal Agents
  • Humans
  • Liver Neoplasms / secondary
  • Magnetic Resonance Imaging
  • Multiple Endocrine Neoplasia Type 1
  • Neoplasm Staging
  • Octreotide
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery*
  • Positron-Emission Tomography
  • Receptors, Somatostatin / metabolism
  • Terminology as Topic
  • Vipoma / diagnosis

Substances

  • Gastrointestinal Agents
  • Receptors, Somatostatin
  • Octreotide